can you buy stock in pot? Guide

Can You Buy Stock in Pot?

can you buy stock in pot — short answer: yes. This guide explains how investors can gain exposure to the legal cannabis industry ("pot") through publicly traded companies, exchange-traded funds (ETFs), real estate investment trusts (REITs), over-the-counter (OTC) listings, fractional shares, and derivatives. You will learn practical steps to buy cannabis-related securities, legal and banking considerations, common risks, evaluation criteria, and where Bitget fits into the process.

As of January 2026, according to U.S. News and other sector coverage, investor interest in cannabis remains strong even as the industry navigates evolving regulation and episodic volatility. This article is beginner-friendly, neutral, and factual — not investment advice. It focuses strictly on financial exposure to "pot" (the legal cannabis industry).

Overview of the Cannabis Investment Opportunity

The legal cannabis market includes two primary segments: medical cannabis (pharmaceutical and therapeutic uses) and recreational cannabis (adult-use sales). Market estimates vary by source, but many forecasts show meaningful growth over the coming decade as legalization expands across U.S. states and additional countries.

• Market size and growth: estimates depend on scope (domestic vs. global). Some industry forecasts that track licensed retail sales place the U.S. legal cannabis market in the tens of billions of dollars in annual retail sales today, with global projections ranging broadly. Analysts often cite compound annual growth rates (CAGR) in the mid-to-high single digits to low double digits for legalized markets through the late 2020s and early 2030s.

• Segments and value chain: core segments include cultivation and production (growers), processors and product manufacturers (edibles, extracts), retail dispensaries, cannabis-focused biotechnology (plant-derived therapeutics and R&D), and ancillary service providers (packaging, compliance software, payments, logistics).

• Why investors are interested: the combination of expanding legalization, new product formats, potential institutional adoption, and recurring retail demand makes the sector a thematic play for growth-oriented investors. Legislative changes (for example, federal reclassification or state-level adult-use legalization) can act as catalysts.

Note: market access varies by country and jurisdiction. Licensing, taxation, and banking access influence company economics and investor access.

How You Can Buy “Pot” — Main Investment Routes

Below are the principal routes investors use when asking "can you buy stock in pot?" Each route carries different risk/return characteristics and practical constraints.

Individual Public Cannabis Stocks

Buying individual cannabis stocks means purchasing equity in companies directly exposed to the cannabis value chain. Typical categories include:

• Growers and producers: companies focused on cultivation and the sale of dried flower or extracts.
• Retailers/dispensaries: firms that operate storefronts or delivery services in legalized jurisdictions.
• Cannabis-focused biotechnology: companies pursuing plant-derived medicines, clinical trials or novel formulations.
• Ancillary services and technology: providers of software, packaging, testing labs, lighting, and other non-plant exposure.

Many larger and better-known cannabis companies list on major exchanges where permitted (for example, Canadian exchanges) or on U.S. exchanges when they meet listing requirements; others trade on OTC markets. Individual equities can offer concentrated returns but come with company-specific execution risk.

Cannabis Exchange-Traded Funds (ETFs)

Cannabis ETFs are pooled funds that hold a basket of cannabis-related stocks and provide diversified sector exposure in a single trade. ETFs are useful if you want to avoid stock-picking and gain broad exposure to the industry. Common ETF approaches include:

• Market-cap-weighted sector ETFs holding large-cap cannabis companies.
• Thematic ETFs blending U.S. and Canadian operators, ancillary service providers, and biotech names.

ETFs offer diversification, intraday liquidity, and familiar trading mechanics for most investors.

Real Estate Investment Trusts (REITs) and Specialty Funds

Cannabis-related REITs own or finance properties leased to cannabis operators (cultivation facilities, processing plants, dispensaries). These REITs provide indirect exposure to the sector with a property- and lease-focused risk/return profile. Compared with operators, REITs often generate rental income and may trade more like traditional commercial real estate REITs, though they remain exposed to tenant and regulatory risk.

Example: Innovative Industrial Properties (IIPR) is a cannabis-focused REIT (example company mentioned for illustration).

Over-the-Counter (OTC) and ADR Listings

Because of federal legal constraints in some jurisdictions, many U.S. cannabis operators and smaller foreign companies trade on OTC markets in the U.S. OTC shares often have lower liquidity, wider spreads, reduced disclosure requirements, and greater price volatility. American Depositary Receipts (ADRs) may be used by foreign cannabis companies to list in the U.S. financial system but are less common for this sector.

When asking "can you buy stock in pot?" you should understand that many U.S.-based consumer-facing growers and operators are available only OTC, which affects trade execution and risk.

Fractional Shares, Brokerages, and Platforms

Many brokerages now offer fractional shares, allowing investors to buy a small dollar amount of an expensive cannabis stock or ETF rather than a full share. This lowers the barrier to entry for novice investors and enables dollar-cost averaging into positions. Curated cannabis theme baskets may also be available at some brokerages.

Important: when selecting a broker to act on "can you buy stock in pot?" consider commission costs, available products, margin and derivatives access, and whether the platform supports the specific tickers you want.

Derivatives, CFDs and International Instruments

Some trading platforms provide derivatives or CFDs (contracts for difference) tied to cannabis equities or ETFs. These instruments enable leveraged exposure but increase risk and are subject to different regulation in each jurisdiction. Derivatives can be useful for short-term trading or hedging but are not appropriate for all investors.

If you prefer a regulated spot market and custody, ETFs and listed equities are usually more straightforward than leveraged contracts.

Practical Steps to Buy Cannabis Stocks

If you’ve decided to explore "can you buy stock in pot?" here is a step-by-step practical workflow.

1. Choose a brokerage or trading platform (for example, Bitget for supported equities and ETFs). Verify that the platform lists the specific cannabis tickers or ETFs you want to buy and whether fractional shares are offered.
2. Research tickers and funds. Use company filings, ETF holdings, earnings reports, and independent analyst coverage to understand exposure and fundamentals.
3. Decide your allocation and risk limits. Given the sector’s volatility, many investors limit position sizes or use small diversified allocations.
4. Select order type: market orders for immediate execution or limit orders to control price.
5. Execute the trade, confirm settlement and custody arrangements, and monitor positions.
6. Review tax and reporting implications in your jurisdiction and keep records for capital gains and holdings.

Representative examples of tickers/types you may encounter when asking "can you buy stock in pot?":

• Canopy Growth — CGC (example large-cap cannabis company).
• Green Thumb — commonly traded on OTC venues (example OTC exposure).
• Trulieve — commonly traded on OTC venues (example OTC exposure).
• Innovative Industrial Properties — IIPR (cannabis REIT example).
• ETF example — MJ (an ETF ticker often used for cannabis sector exposure).

(These examples are illustrative; check current listings and availability on Bitget or your chosen broker.)

Legal, Regulatory, and Banking Considerations

Legal status and banking access are central to the question "can you buy stock in pot?" because regulatory frameworks shape corporate operations and investor access.

• U.S. federal status: in the United States, cannabis remains federally controlled in many respects. Federal illegality affects cross-border listings, access to U.S. banking services for cannabis businesses, and financing options. Federal reclassification or rescheduling would materially change the industry’s operating environment and investor access.

• State vs. federal rules: many U.S. states have implemented medical or adult-use legalization, creating large state-licensed markets. However, companies that operate across multiple states must navigate a complex patchwork of laws.

• Canada and other jurisdictions: Canada legalized adult-use cannabis nationally in 2018, enabling many Canadian-listed cannabis companies to access public capital markets more readily. Parts of Europe and Latin America have varying regulated markets, each with unique compliance standards.

• Banking and finance: because of legal constraints, some cannabis businesses face difficulty obtaining traditional banking services and loans. This can affect cash handling, payroll, and capital expenditure planning.

• Listing venues: regulatory status determines listing venues — some companies list on major exchanges in countries with national legalization; others list on OTC markets where listing standards differ.

As of January 2026, according to coverage from The Motley Fool and other industry publications, regulatory developments — including any news about rescheduling or major federal legislative initiatives — remain important catalysts for listed cannabis equities.

Key Risks of Investing in Cannabis Stocks

When answering "can you buy stock in pot?" investors must weigh notable risks:

• Legal and political risk: changes in law, delayed or failed legislation, or shifts in enforcement can materially impact revenues and valuation.
• High volatility: cannabis equities have historically experienced dramatic rallies and pullbacks tied to sentiment and news.
• Supply/demand imbalances: production gluts, pricing pressure in key markets, or product oversupply can hurt margins.
• Company execution risk: failed product launches, regulatory violations, or poor capital allocation can damage stock performance.
• Valuation risk: sector enthusiasm has sometimes pushed company valuations ahead of fundamentals.
• OTC-specific risk: weaker disclosure, lower liquidity, and wider spreads raise trading risk for OTC-listed cannabis operators.

No single risk list is exhaustive; investors should perform ongoing monitoring.

How to Evaluate Cannabis Companies

Thorough due diligence helps answer "can you buy stock in pot?" with greater confidence. Key evaluation points include:

• Business model: is the company a cultivator, retailer, processor, biotech, or ancillary services provider? Revenue and margin drivers differ by model.
• Revenue growth and profitability: assess top-line growth, gross margins, and operating losses or profits.
• Cash position and access to capital: capital-intensive cultivation and retail expansion require steady financing; check balance sheets and cash burn rates.
• Regulatory footprint: examine which states or countries the company operates in, license durability, and compliance history.
• Management quality and track record: executive experience in regulated industries and capital markets matters.
• Distribution and brand strength: retail presence, wholesale contracts, and brand differentiation affect durability.
• Catalysts and constraints: upcoming regulatory decisions, market expansions, or product approvals can be catalysts; license expirations, banking restrictions, or regulatory investigations are constraints.

Quantitative metrics (revenue per gram, same-store sales growth, cash runway) and qualitative factors (supply chain resilience, licensing relationships) both matter.

Market History and Outlook

Cannabis equities have experienced boom-and-bust cycles since legalization momentum accelerated in the mid-2010s. Key drivers of past rallies include major legalization steps, investor enthusiasm for new markets, and high-profile M&A activity. Corrections have followed periods of oversupply, disappointing earnings, and slow progress on federal reform.

Looking forward, the sector’s outlook depends heavily on regulatory developments, consumer adoption patterns, pricing dynamics, and capital availability. Many analysts continue to cite legalization expansion and product innovation (edibles, extracts, wellness products) as structural tailwinds, while cautioning about near-term volatility.

Alternatives and Complementary Investments

If you are exploring "can you buy stock in pot?" but want diversified or lower-risk exposure, consider alternatives:

• Ancillary suppliers: companies that sell to cannabis operators (lighting, testing labs, packaging) often avoid direct plant-based regulatory constraints.
• Tobacco or consumer packaged goods (CPG) partnerships: major CPG and tobacco firms testing CBD or cannabis-adjacent products can provide indirect exposure.
• Private equity and venture capital: direct private investments in growth-stage cannabis companies are another route, often requiring accredited investor status.
• Non-equity exposures: corporate bonds (where available), structured products, or ownership of physical real assets (warehouses leased to operators) are additional options.

Each alternative has its own liquidity, regulatory and due diligence profile.

Tax, Accounting, and Reporting Considerations

The tax and accounting landscape for cannabis companies is more complex in jurisdictions where cannabis is federally illegal.

• Special tax rules: in the U.S., for example, IRC Section 280E historically restricted deductibility of many business expenses for companies trafficking controlled substances under federal law, affecting reported profitability. Where such rules apply, company margins reported on tax returns can differ markedly from GAAP or IFRS measures.
• Accounting complexities: revenue recognition, inventory accounting, and impairment considerations can be non-standard for cannabis businesses.
• Investor implications: investors should be prepared for unusual tax disclosures and differing measures of profit depending on whether tax or accounting standards are used.

Consult tax professionals for jurisdiction-specific guidance; public filings also disclose relevant company-level tax considerations.

Common Questions (FAQ)

Q: Is it legal to buy cannabis stocks? A: Yes — in most jurisdictions you can legally buy publicly traded cannabis stocks. The legal status of cannabis itself does not necessarily prevent you from owning shares in companies that operate in regulated markets. Your ability to trade depends on whether brokers list the securities in your country.

Q: Are cannabis stocks listed on major exchanges? A: Some cannabis companies list on major exchanges in jurisdictions with permissive national rules (e.g., Canada). Many U.S.-based operators historically traded on OTC markets, although listings and delistings vary with regulatory developments.

Q: What are the safest ways to get exposure to pot stocks? A: "Safest" is relative. Diversified ETFs and large-cap REITs or ancillary companies are often less risky than single small-cap growers. Using lower allocation sizes and dollar-cost averaging can reduce single-event exposure. These approaches address some idiosyncratic risks but do not eliminate sector risk.

Q: How does DEA rescheduling affect stocks? A: Rescheduling or decriminalization at the federal level could ease banking restrictions, lower compliance costs, and broaden institutional participation — often viewed as potential positive catalysts for many cannabis equities. The exact market impact depends on policy details and market expectations.

Glossary

• OTC: Over-the-counter market where securities trade outside major exchanges; often lower liquidity and disclosure.
• ETF: Exchange-traded fund; a pooled product that trades like a stock and holds a basket of securities.
• REIT: Real estate investment trust; a company that owns or finances income-producing real estate and distributes income to shareholders.
• Schedule I/III (DEA): DEA scheduling categories under U.S. federal law; Schedule I denotes substances considered to have high abuse potential and no accepted medical use under federal law (historically applied to cannabis in the U.S.). Rescheduling would change classification and regulatory treatment.
• Fractional shares: Portions of a single share that allow investors to buy less than one full share.
• Ancillary companies: Businesses that supply goods or services to cannabis companies but do not handle the plant product directly (e.g., software, packaging).

See Also

• Cannabis legalization by jurisdiction — compare state and national rules.
• How to invest in ETFs — basics of ETF investing and risk.
• Cannabis biotech — R&D and drug development in plant-based therapeutics.
• Sector-specific due diligence checklist — step-by-step research guide for regulated consumer industries.

References

• "How to Buy Canopy Growth Stock (CGC)" — The Motley Fool. As of January 2026, The Motley Fool has published step-by-step guides to buying major cannabis equities.
• "These 6 Cannabis Stocks Popped The Most on Rescheduling Plans" / "How to buy marijuana stocks" — NerdWallet. As of early 2026 coverage, NerdWallet summarized recent mover stocks and how rescheduling news affected prices.
• "How to invest in marijuana & cannabis companies" — Public.com. Public.com provides a beginner-friendly investing overview and examples.
• "Investing in marijuana for beginners" — Stash. Stash published beginner guidance and allocation considerations as of 2025–2026 coverage.
• "7 Best Marijuana Stocks and ETFs to Buy in 2026" — U.S. News. As of January 2026, U.S. News listed leading cannabis sector ETFs and equities.
• "Best Marijuana Stocks for 2026: Cannabis Investing" / "7 Steps to Investing in Marijuana Stocks" — The Motley Fool. Multiple how-to pieces provide practical steps and stock lists.
• "How to invest in cannabis stocks" — Saxo. Saxo’s guide covers ETF vs individual stock exposure.
• "The Ultimate List of Cannabis Stocks" — Barchart. A compiled list of public cannabis-related tickers and market data.
• "How to Invest in Cannabis Stocks – A Simple Guide for Beginners" — SH Financial. Beginner guide to the sector and risk points.

Note: The above references reflect sector coverage and guidance from general investor education sources; check each provider’s latest reporting date and filings for up-to-date data.

How Bitget Can Help

If you decide to act after reading about "can you buy stock in pot?" Bitget provides a regulated trading interface for equities and ETFs where available, fractional share capabilities, and custody services. For wallet management related to crypto-linked products, consider Bitget Wallet for secure custody and interoperability.

Further explore Bitget’s supported products and educational resources to understand available cannabis ETFs and equities in your jurisdiction. Always confirm local availability and regulatory compliance before trading.

Final Notes and Next Steps

If your primary question is "can you buy stock in pot?" the practical answer is yes, through multiple routes. Start by clarifying your investment objectives, doing careful due diligence, and choosing a trading platform like Bitget that lists the securities or ETFs you want to trade. Keep regulatory and tax implications in mind, limit allocation sizes when entering a volatile sector, and monitor news-driven catalysts closely.

Want to get started? Review Bitget’s trading products and consider practicing with small, diversified positions or ETFs to gain experience while managing risk.